Loop Diuretics: Clinical Trials

3 trials of Loop Diuretics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Unknown 1

Follow Loop Diuretics: new trials by email Literature Review of Loop Diuretics trials Research Report on Loop Diuretics

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sequential Nephron Blockade in Acute Heart Failure
Metolazone, Loop Diuretics - Acute Heart Failure
Phase 3UnknownPoliclinico Casilino ASL RMB3102019-10-012019-11-19
Diuretic Response in Advanced Heart Failure: Bolus Intermittent vs Continuous INfusion
Loop Diuretics - Heart Failure NYHA Class III, Heart Failure NYHA Class IV
Phase 3CompletedUniversity of Turin, Italy802013-05-012018-07-19
Determining Optimal Dose and Duration of Diuretic Treatment in People With Acute Heart Failure (The DOSE-AHF Study)
Furosemide-Q12 hour bolus, Furosemide-Continuous Infusion, Furosemide-Low Intensification - Heart Failure
Phase 3CompletedDuke University3082008-02-012018-03-06

Conditions studied

Edema (1)  ·  Heart Failure (1)

Sponsors

Duke University (1)  ·  Policlinico Casilino ASL RMB (1)  ·  University of Turin, Italy (1)

Countries

Italy (2)  ·  Canada (1)  ·  United States (1)

Top investigators

Eugene Braunwald, MD (1)  ·  Gennaro Cice, MD (1)  ·  Kerry L. Lee, PhD (1)  ·  Simone Frea, MD (1)

Results publications

PMID 21366472, PMID 23194486, PMID 23250981, PMID 25543972, PMID 26041600, PMID 26927285, PMID 27514750, PMID 31256261, PMID 38775253

NIH funding

U01HL084904 (1)